Novel Cancer Treatment Headed to McLaren Flint

An innovative new technology headed to Flint will be used to treat cancer with proton therapy. The McLaren Proton Therapy Center is the first to receive the new machine that treats patients upright, enabling cancer treatment with more precision. 

Leo Cancer Care developed the proton therapy called “Marie,” which will take up less space yet provide more accurate treatments since there will be less organ movement. 

The Proton Therapy Center in Flint will receive the first two upright units and be used within the next two years, pending FDA approval. The largest proton center in Michigan, the new machine will allow more patients to be treated. 

According to a news release from McLaren, proton therapy is a type of radiation therapy that uses protons to accurately target tumor cells and leave healthy surrounding cells undamaged.

Stephen Towe, CEO of Leo Cancer Care, said, “The goal of Leo Cancer Care and McLaren Proton Therapy Center’s collaboration is to bring proton therapy to more patients, and we know there are clear advantages with proton therapy. The McLaren Proton Therapy Center is well-positioned to become the first to potentially treat patients with the revolutionary Leo Cancer Care technology.”

Construction to add the “Marie” units to the Proton Therapy Center in Flint will start in the spring of 2023 and be fully operational by the fall of 2024.  

Acceletronics is an industry leader in delivering the best equipment performance and service reliability from CT Scanners and Linear Accelerators across all major brands and models. Call 610-524-3300 to learn more.

Written by the digital marketing team at Creative Programs & Systems: https://www.cpsmi.com/

AI Tools Launched at Radiology Center for Breast Cancer 

US Radiology Specialists has partnered with Artificial Intelligence (AI) company Volpara Health to form superior mammography and breast cancer services at Charlotte Radiology in North Carolina. 

Novel analytics performed by Volpara Health’s AI will execute risk assessment, patient communication, reports, quality assurance, and breast density analytics. 

Lindsay Muns, group president of physician practices for US Radiology and CEO of Charlotte Radiology and Upstate Carolina Radiology, said, “With each of our 16 breast imaging centers now equipped with the latest Volpara software tool suite, Charlotte Radiology can better fulfill our most important mission: diagnosing breast cancer early and supporting our patients through their treatment. Implementing advanced technologies like these help us continuously improve both experiences and outcomes for our patients across the Carolinas.”

Amy Sobel, MD, section chief of Charlotte Radiology Breast Imaging, said, “Our partnership with Volpara allows us as radiologists to keep our focus where we need it: on each patient we see. With Volpara, we are assured of accurate and timely reporting, as well as high quality data. This streamlines our workflow and helps us deliver excellent patient care as a team.” 

Across the United States, AI is being implemented at an accelerated rate due to improving cancer care. 

At the Miami Cancer Institute, data from analytics company COTA were used to formulate insights to identify the BRCA gene. This research led to the implementation of total BRCA mutation testing for all newly diagnosed breast cancer. 

Now, a new partnership will focus on minimizing health disparities and gaps in cancer treatment, as preventative care was severely affected by the COVID-19 pandemic.

The National Cancer Institute (NCI) reported in 2021 that the global pandemic resulted in drastic decreases in cancer screening tests. Without early detection and treatment, many patients suffered from larger growths or more advanced stages of cancer by the time it was eventually detected. 

The COVID-19 pandemic did bring some innovation to cancer screening, however. By using video conferencing tools, education about screening and personalized tests was made possible. 

________________________

Acceletronics is an industry leader in delivering the best equipment performance and service reliability from CT Scanners and Linear Accelerators across all major brands and models. Call 610-524-3300 to learn more.

Written by the digital marketing team at Creative Programs & Systems: https://www.cpsmi.com/

Using Medical Radiation Detectors

By 2030, the global medical radiation detection market is projected to reach $2,558.1 million; in 2020, the market was valued at $1,173 million, according to a new report from Researchandmarkets.com.

A variety of fatal illnesses can result when people are exposed to radiation for an extended period. Radiation detectors are medical equipment solutions that can detect the presence of radiation. Handheld Survey Meter (HSM), Personal Radiation Detector (PRD), Radiation Portal Monitor (RPM), and Radiation Isotope Identification Device are some of the options available to detect radioactive materials and ionizing radiation.

Dosimeters, radiation-detecting equipment, can detect Gamma rays, which are the most dangerous. Cancer rates have been rising, accelerating the need for medical radiation detecting equipment. An increase in diagnostic imaging facilities requiring medical radiation detectors has helped avoid unnecessary exposure.

Encouraging awareness in radiation-prone settings has been crucial when it comes to safety. In the upcoming years, the increased potential for medical radiation detection is expected to expand in emerging markets.

There are different branches of the global medical radiation detection market, including detection type, product, end-user, and region. Each category contains its sub-categories as well. All of these segments are what drive market growth.

Acceletronics is an industry leader in delivering the best equipment performance and service reliability from CT Scanners and Linear Accelerators across all major brands and models. Call 610-524-3300 or visit our website: https://www.acceletronics.com.

Written by the digital marketing staff at Creative Programs & Systems: www.cpsmi.com.

Novel AI Might Predict Heart Attacks

New research published in the Journal of Nuclear Medicine shows how physicians can use Artificial Intelligence (AI) to predict heart attacks. The study included 293 participants with coronary artery disease; 22 people experienced a myocardial event during the 53-month follow-up period.

When used in combination with F-sodium fluoride (F-NaF) and quantitative coronary plaque analysis (via CT angiography) along with clinical findings, physicians can easily predict the risk of myocardial infractions.

Predicting heart attacks has been challenging in everyday clinical practice and is typically based on cardiovascular risk factors. Patients with coronary artery disease can have underlying conditions despite high scores.

Pitor J. Slomka, Ph.D., FACC, FASNC, FCCPM, director of Innovation in Imaging at Cedars-Sinai Medical Center in Los Angeles, said, “Recently, advanced imaging techniques have demonstrated considerable promise in determining which coronary artery disease patients are most at risk for a heart attack. These techniques include 18F-sodium fluoride (18F-NaF) PET, which assesses disease activity in the coronary arteries, and CT angiography, which provides a quantitative plaque analysis. Our goal in the study was to investigate whether the information provided by 18F-NaF PET and CT angiography is complementary and could improve prediction of heart attacks with the use of artificial intelligence techniques.”

The AI-assisted process exhibited a significant advancement in predicting heart attacks rather than employing clinical data alone.

Slomka said, “F-NaF PET combined with anatomical imaging provided by CT angiography has the potential to enable precision medicine by guiding the use of advanced therapeutic interventions. Our study supports the use of artificial intelligence methods for integrating multimodality imaging and clinical data for robust prediction of heart attacks.”

Acceletronics is an industry leader in delivering the best equipment performance and service reliability from CT Scanners and Linear Accelerators across all major brands and models. Call 610-524-3300 or visit our website: https://www.acceletronics.com.

Written by the digital marketing staff at Creative Programs & Systems: www.cpsmi.com.

Novel AI Might Predict Heart Attacks

New research published in the Journal of Nuclear Medicine shows how physicians can use Artificial Intelligence (AI) to predict heart attacks. The study included 293 participants with coronary artery disease; 22 people experienced a myocardial event during the 53-month follow-up period.

When used in combination with F-sodium fluoride (F-NaF) and quantitative coronary plaque analysis (via CT angiography) along with clinical findings, physicians can easily predict the risk of myocardial infractions.

Predicting heart attacks has been challenging in everyday clinical practice and is typically based on cardiovascular risk factors. Patients with coronary artery disease can have underlying conditions despite high scores.

Pitor J. Slomka, Ph.D., FACC, FASNC, FCCPM, director of Innovation in Imaging at Cedars-Sinai Medical Center in Los Angeles, said, “Recently, advanced imaging techniques have demonstrated considerable promise in determining which coronary artery disease patients are most at risk for a heart attack. These techniques include 18F-sodium fluoride (18F-NaF) PET, which assesses disease activity in the coronary arteries, and CT angiography, which provides a quantitative plaque analysis. Our goal in the study was to investigate whether the information provided by 18F-NaF PET and CT angiography is complementary and could improve prediction of heart attacks with the use of artificial intelligence techniques.”

The AI-assisted process exhibited a significant advancement in predicting heart attacks rather than employing clinical data alone.

Slomka said, “F-NaF PET combined with anatomical imaging provided by CT angiography has the potential to enable precision medicine by guiding the use of advanced therapeutic interventions. Our study supports the use of artificial intelligence methods for integrating multimodality imaging and clinical data for robust prediction of heart attacks.”

Acceletronics is an industry leader in delivering the best equipment performance and service reliability from CT Scanners and Linear Accelerators across all major brands and models. Call 610-524-3300 or visit our website: https://www.acceletronics.com.

Written by the digital marketing staff at Creative Programs & Systems: www.cpsmi.com.

Henry Ford Health System Implants Novel Therapy for Brain Tumors

Surgeons at Michigan’s Henry Ford Health System successfully treated a patient who suffers from a recurrent brain tumor by delivering a dose of radiation therapy directly on the tumor. This new approach could revolutionize treatment by delaying or preventing future tumor cells from regrowing. Called GammaTile Therapy, the surgically targeted radiation therapy was the first of its kind performed in Michigan; the patient was a 41-year-old male.

Adam Robin, M.D., a neurosurgeon at the Hermelin Brain Tumor Center at Henry Ford, said, “The current standard of care for brain tumors is tumor resection, often followed by radiation, chemotherapy, or a combination of both. Approximately half of patients treated for brain tumors experience tumor recurrence within a year. In his most recent surgery, the patient was treated with a form of surgically targeted radiation therapy, which targets residual tumor cells with radiation before they can significantly replicate. Our hope is this therapy will delay or prevent the tumor cells from replicating and forming a recurrent tumor.”

GammaTile Therapy is cleared by the FDA and designed to delay tumor regrowth while protecting healthy brain tissue in patients who suffer from recurring tumors.

Mira M. Shah, M.D., a radiation oncologist at Henry Ford, external beam radiation therapy is usually delivered no sooner than two- to three weeks after surgery to let the incision heal. With GammaTile, the radiation is focused on specific areas of the brain using a type of brachytherapy (internal radiation) which delivers a therapeutic dose to the tumor during surgery.

Leaving the healthy tissue unharmed, GammaTile maximizes the amount of radiation aimed at the tumor and is critical for those patients who have received external beam radiation therapy, which exposes healthy tissue to radiation.

A bioresorbable, conformable 3D-collaten tile uses uniformly spaced radiation sources to target the tumor cavity after the tumor is removed. In just 33 days, 90 percent of the radiation dose is delivered, and after 100 days, the GammaTiles are considered free from radiation. The placement of GammaTile takes approximately five minutes.

Acceletronics is an industry leader in delivering the best equipment performance and service reliability from CT Scanners and Linear Accelerators across all major brands and models. Call 610-524-3300 or visit our website: https://www.acceletronics.com.

Written by the digital marketing staff at Creative Programs & Systems: www.cpsmi.com.

Henry Ford Health System Implants Novel Therapy for Brain Tumors

Surgeons at Michigan’s Henry Ford Health System successfully treated a patient who suffers from a recurrent brain tumor by delivering a dose of radiation therapy directly on the tumor. This new approach could revolutionize treatment by delaying or preventing future tumor cells from regrowing. Called GammaTile Therapy, the surgically targeted radiation therapy was the first of its kind performed in Michigan; the patient was a 41-year-old male.

Adam Robin, M.D., a neurosurgeon at the Hermelin Brain Tumor Center at Henry Ford, said, “The current standard of care for brain tumors is tumor resection, often followed by radiation, chemotherapy, or a combination of both. Approximately half of patients treated for brain tumors experience tumor recurrence within a year. In his most recent surgery, the patient was treated with a form of surgically targeted radiation therapy, which targets residual tumor cells with radiation before they can significantly replicate. Our hope is this therapy will delay or prevent the tumor cells from replicating and forming a recurrent tumor.”

GammaTile Therapy is cleared by the FDA and designed to delay tumor regrowth while protecting healthy brain tissue in patients who suffer from recurring tumors.

Mira M. Shah, M.D., a radiation oncologist at Henry Ford, external beam radiation therapy is usually delivered no sooner than two- to three weeks after surgery to let the incision heal. With GammaTile, the radiation is focused on specific areas of the brain using a type of brachytherapy (internal radiation) which delivers a therapeutic dose to the tumor during surgery.

Leaving the healthy tissue unharmed, GammaTile maximizes the amount of radiation aimed at the tumor and is critical for those patients who have received external beam radiation therapy, which exposes healthy tissue to radiation.

A bioresorbable, conformable 3D-collaten tile uses uniformly spaced radiation sources to target the tumor cavity after the tumor is removed. In just 33 days, 90 percent of the radiation dose is delivered, and after 100 days, the GammaTiles are considered free from radiation. The placement of GammaTile takes approximately five minutes.

Acceletronics is an industry leader in delivering the best equipment performance and service reliability from CT Scanners and Linear Accelerators across all major brands and models. Call 610-524-3300 or visit our website: https://www.acceletronics.com.

Written by the digital marketing staff at Creative Programs & Systems: www.cpsmi.com.

Augmented Reality (AR) Becoming an Aspect of Surgery

ClariffEye, an industry-first solution that combines 2D and 3D visualizations, uses a 3D Augmented Reality (AR) system to enable surgeons to define and navigate through real-time. Royal Phillips announced the first patients had been successfully treated using ClariffEye at Sant Joan de Deu Barcelona Children’s Hospital in Spain along with the Armed Forces Hospital, Oman.

Philips integrated Spine Suite was used by both surgeons, which showcases the Azurion Hybrid Operating Room (OR) in conjunction with ClariffEye. Both surgeries performed with ClariffEye were spinal.

“The level of success of this surgery would not have been possible to reach without ClarifEye,” said Dr. Alejandro Peiró, Orthopedic surgeon and pediatric traumatologist at Sant Joan de Déu Barcelona Children’s Hospital.

Dr. Ahmed Al Jahwari, Head of Department Orthopedics and Spine Surgery at Hospital MoD, Oman, said, “Philips’ new technology enables us to perform less invasive procedures and produce better outcomes for patients with spine conditions. Thanks to the high quality of the intraoperative cone beam CT imaging and the positioning flexibility of the ClarifEye system, we can ensure that implants are in place which lowers post-operative CT scans to check implant placements.”

Spinal procedures can be challenging and fragile to maneuver for surgeons. Delicate neurological and vascular structures near the spine are susceptible to damage. Minimally-invasive techniques have become more prevalent thanks to recent technology, which reduces blood loss, soft tissue damage, and post-operative discomfort.

With ClariffEye, surgeons can utilize real-time imaging in addition to 3D navigation to increase accuracy and improve outcomes.

According to Science Reports, ClariffEye performed accurately better compared to open surgery without 3D navigation. Additionally, ClariffEye has a 98 percent accurate ability to place a pedicle screw during minimally invasive procedures.

“We’re excited that international access to ClarifEye is expanding, and more hospitals and patients will get to experience its benefits firsthand,” said Karim Boussebaa, General Manager Image Guided Therapy Systems at Philips. “As the latest addition to Spine Suite, ClarifEye adds a new dimension in surgical precision for patients. It is a great example of how we’re innovating procedures and helping clinicians to deliver on the Quadruple Aim of better health outcomes, improve patient experience and staff satisfaction, and lower cost of care.”

Acceletronics is an industry leader in delivering the best equipment performance and service reliability from CT Scanners and Linear Accelerators across all major brands and models. Call 610-524-3300 or visit our website: https://www.acceletronics.com.

Written by the digital marketing staff at Creative Programs & Systems: www.cpsmi.com.

Augmented Reality (AR) Becoming an Aspect of Surgery

ClariffEye, an industry-first solution that combines 2D and 3D visualizations, uses a 3D Augmented Reality (AR) system to enable surgeons to define and navigate through real-time. Royal Phillips announced the first patients had been successfully treated using ClariffEye at Sant Joan de Deu Barcelona Children’s Hospital in Spain along with the Armed Forces Hospital, Oman.

Philips integrated Spine Suite was used by both surgeons, which showcases the Azurion Hybrid Operating Room (OR) in conjunction with ClariffEye. Both surgeries performed with ClariffEye were spinal.

“The level of success of this surgery would not have been possible to reach without ClarifEye,” said Dr. Alejandro Peiró, Orthopedic surgeon and pediatric traumatologist at Sant Joan de Déu Barcelona Children’s Hospital.

Dr. Ahmed Al Jahwari, Head of Department Orthopedics and Spine Surgery at Hospital MoD, Oman, said, “Philips’ new technology enables us to perform less invasive procedures and produce better outcomes for patients with spine conditions. Thanks to the high quality of the intraoperative cone beam CT imaging and the positioning flexibility of the ClarifEye system, we can ensure that implants are in place which lowers post-operative CT scans to check implant placements.”

Spinal procedures can be challenging and fragile to maneuver for surgeons. Delicate neurological and vascular structures near the spine are susceptible to damage. Minimally-invasive techniques have become more prevalent thanks to recent technology, which reduces blood loss, soft tissue damage, and post-operative discomfort.

With ClariffEye, surgeons can utilize real-time imaging in addition to 3D navigation to increase accuracy and improve outcomes.

According to Science Reports, ClariffEye performed accurately better compared to open surgery without 3D navigation. Additionally, ClariffEye has a 98 percent accurate ability to place a pedicle screw during minimally invasive procedures.

“We’re excited that international access to ClarifEye is expanding, and more hospitals and patients will get to experience its benefits firsthand,” said Karim Boussebaa, General Manager Image Guided Therapy Systems at Philips. “As the latest addition to Spine Suite, ClarifEye adds a new dimension in surgical precision for patients. It is a great example of how we’re innovating procedures and helping clinicians to deliver on the Quadruple Aim of better health outcomes, improve patient experience and staff satisfaction, and lower cost of care.”

Acceletronics is an industry leader in delivering the best equipment performance and service reliability from CT Scanners and Linear Accelerators across all major brands and models. Call 610-524-3300 or visit our website: https://www.acceletronics.com.

Written by the digital marketing staff at Creative Programs & Systems: www.cpsmi.com.

Fewer Imaging Exams Scheduled During Virtual Visits

New research published in the JAMA Network Open suggests primary care visits that take place via video or phone result in fewer imaging scan orders.

The COVID-19 pandemic has fueled telehealth as a primary way for physicians to offer patient care. As patients stay home to limit exposure to the virus, physician follow-up care can look different.

Using pre-pandemic data from more than 1.1 million patients, Kaiser Permanente researchers found that primary care doctors ordered imaging in roughly 59 percent of office visits versus 29 percent of virtual and 27 percent over the phone.

The study did not specify the reason behind the variance; however, the authors suggested patients who were more ill might have sought out in-person primary care.

Mary Reed, DrPH, a Kaiser Permanente research scientist, said, “It is possible that these differences in treatment might be driven by the types or seriousness of concerns that patients chose for each visit type, or by the degree to which physicians could assess the patient in each visit type. We need to explore these details further in future research.”

The study analyzed primary care appointments at Kaiser Permanente in Northern California between 2016 and midway through 2018; almost 2.2 million were evaluated. Video and telephone visits resulted in a lower number of medications prescribed (39 percent and 35 percent, respectively) compared to office-based visits, which were at 52 percent.

Overall, 25 percent of video visits required a follow-up appointment within a week. Telephone and in-person visits required follow-ups at 26 percent and 24.5 percent, respectively.

Emergency department visits or hospitalizations did not see a difference.

The study wrote, “In contrast to prior studies of direct-to-consumer telemedicine, we did not find evidence of over-ordering or over-prescribing among patients using telemedicine to visit their own primary care doctors. Video or telephone visits may be a convenient and safe way for patients to address some primary care needs without generating a substantial number of follow-up office visits or experiencing health events.”

Acceletronics is an industry leader in delivering the best equipment performance and service reliability from CT Scanners and Linear Accelerators across all major brands and models. Call 610-524-3300 or visit our website: https://www.acceletronics.com.

Written by the digital marketing staff at Creative Programs & Systems: www.cpsmi.com.